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Management of pancreatic pseudocysts
RW Parks, G Tzovaras, T Diamond, BJ Rowlands*
Surgical Unit, Mater Hospital, Belfast and Professorial Surgical Unit, Queen's University, Royal Victoria Hospital,
Belfast, UK
Background: This review analyses the outcome for patients with acute and chronic
pancreatic pseudocysts managed in two major referral centres.
Patients and Methods: From 1987 to 1997, 33 patients were treated with either acute (n =
19) or chronic (n = 14) pseudocysts. Procedures performed included cystgastrostomy
(64%o), cystduodenostomy (6%), cystjejunostomy (3%), distal pancreatectomy with
resection of pseudocyst (12%), laparotomy with external drainage (9%), endoscopic
transpapillary stenting (3%) and endoscopic pancreatic duct sphincterotomy with
percutaneous drainage of the pseudocyst (3%).
Results: All patients had resolution of their pseudocyst and no patient developed
recurrence. There were no deaths in this series. There was a 9% incidence of major
complications and a 21% incidence of minor complications. Outcome was excellent in
63% and good in 27% of patients. Two patients (6%) had persistent chronic pain and one
patient (3%) had evidence of exocrine pancreatic insufficiency with malabsorption.
Conclusions: Surgical internal drainage of pancreatic pseudocysts can be performed
safely with low morbidity and mortality provided patients are carefully selected and
their medical management is optimized. Although minimally invasive techniques now
offer a variety of treatment options, open surgical drainage is still indicated for a
significant number of cases.
Key words: Pancreatic pseudocyst - Pancreatitis - Drainage - Cystgastrostomy -
Cystjejunostomy
pancreatic pseudocysts are localised collections of occurs as a result of pancreatic inflammation and
pancreatic secretions, enclosed in a wall of fibrous ductal disruption.' They are usually a complication of
or granulation tissue lacking an epithelial lining. This acute or chronic pancreatitis, but may also occur
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secondary to pancreatic trauma. Traditionally, they
have been managed by surgical internal drainage but,
recently, less invasive techniques have become
available.2 The aim of this retrospective review was to
analyse the aetiology, presentation, management and
outcome in a series of patients with symptomatic
pancreatic pseudocysts treated in two tertiary referral
units.
Patients and Methods
Between 1987 and 1997, 33 consecutive patients (18
males, 15 females) were treated, of whom 17 cases (52%)
were tertiary referrals. The mean age was 50.4 years
(range, 14-77 years). Using the 1992 Atlanta convention
guidelines,3 patients with an acute fluid collection,
grossly infected cyst or abscess were excluded from this
study. The differentiation between acute fluid
collections and acute pseudocysts is arbitrary. Acute
fluid collections occur early in the course of acute
pancreatitis and lack a wall of granulation tissue,
whereas an acute pseudocyst is a collection of pancreatic
juice enclosed in a wall of fibrous or granulation tissue
which develops four or more weeks after the onset of
acute pancreatitis.
Aetiology
Pseudocyst formation was a complication of acute
pancreatitis in 19 patients and chronic pancreatitis in 14
patients. Aetiological factors included gallstones (11),
alcohol (11), post surgery (2) and hyperlipidaemia (2).
Gallstone pancreatitis was more common in the acute
group (9/19 acute versus 2/14 chronic), whereas alcohol
was more prevalent in the chronic group (6/14 chronic
versus 5/19 acute). No aetiology was identified in 7
cases (idiopathic).
Indications for surgery
The most common factor resulting in a decision to
operate was pain (55%). Others included radiological
evidence of enlargement of the pseudocyst (21%),
jaundice (12%) or gastric outlet obstruction (6%). One
patient (3%) presented following spontaneous
haemorrhage into the pseudocyst 4 weeks after a bout of
acute pancreatitis. A further patient (3%) required
urgent intervention due to iatrogenic rupture of the
pseudocyst during attempted percutaneous aspiration.
The mean time from diagnosis to intervention in the
acute pancreatitis group was 7 weeks and in the chronic
pancreatitis group 12 weeks.
Investigations
All patients were assessed by ultrasonography and 31
(94%) also had a CT scan. ERCP was performed in 14
patients (42%) to demonstrate pancreatic ductal
anatomy. Duct-pseudocyst communication was identi-
fied in 3 patients. Other investigations included barium
meal (18%), OGD (15%), PTC (3%) and HIDA scanning
(3%). The median size of pseudocysts that developed
following a bout of acute pancreatitis (11.3 cm; range,
6-18 cm) was significantly larger than those in patients
with chronic pancreatitis (8.4 cm; range, 3-23 cm) (P
<0.05, Mann Whitney U-test).
Management
The principal surgical procedure undertaken was a
cystgastrostomy which was performed in 21 patients
(64%). Other internal drainage procedures included cyst-
duodenostomy (6%) and cystjejunostomy (3%). Four
patients (12%) underwent a distal pancreatectomy with
resection of a chronic pseudocyst. Laparotomy with
external drainage was performed in three patients (9%)
with acute pseudocysts at 4, 6 and 12 weeks after the
onset of acute pancreatitis. In these cases, it was felt the
cyst wall was too friable for a safe internal drainage
procedure to be performed. One patient (3%) had endo-
scopic transpapillary stenting of a disrupted pancreatic
duct and percutaneous drainage of the pseudocyst, and
a further patient (3%) had an endoscopic pancreatic
duct sphincterotomy followed by percutaneous
drainage of the pseudocyst.
Concomitant procedures were undertaken more
frequently in patients with acute pseudocysts. Of the 19
patients with an acute pseudocyst, 5 underwent a
cholecystectomy, 2 had a cholecystostomy and 5 had a
feeding jejunostomy tube inserted at the time of their
primary operation. Only one of the 14 patients with a
chronic pseudocyst had a simultaneous cholecyst-
ectomy and no feeding jejunostomy tubes were inserted,
indicating the more severe nature of the acute illness
and the greater likelihood of developing complications
due to the primary condition and/or the procedure. One
patient in the acute group and two in the chronic group
had a surgical biliary drainage procedure performed for
biliary duct stricture in addition to operative internal
drainage of their pseudocyst.
Results
All patients had resolution of their pseudocyst and no
patient developed recurrence. There were no deaths.
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Three patients (9%) developed major complications
which resulted in prolonged hospital stay. One patient
had a wound dehiscence, one developed a chest
infection and one had delayed gastric emptying. Seven
patients (21%) experienced minor complications which
did not delay discharge from hospital. Complications
included atelectasis (12%), minor wound infection
(6%) and central line sepsis (3%). All patients who had
external drainage of their pseudocyst developed a
controlled external fistula which closed spontaneously
after 1-3 months. There was no difference in post-
operative complication rates or outcome when com-
paring patients with pseudocysts arising after acute or
chronic pancreatitis.
Eleven patients (33%) were monitored in ICU for a
median of 2 days following surgical intervention. The
median hospital stay was 11 days (range, 6-120 days).
An excellent outcome with no further symptoms was
achieved in 21 patients (63%). A further nine patients
(27%) had a good outcome with minimal symptoms,
predominantly mild episodes of abdominal pain. Two
patients (6%) had persistent chronic pain and one
patient (3%) had evidence of exocrine pancreatic
insufficiency with malabsorption.
Discussion
Surgical internal drainage of pancreatic pseudocysts
was first performed in 1921,4 and since then has
remained the mainstay of treatment for pancreatic
pseudocysts. The recent introduction of minimally
invasive techniques, including percutaneous, endo-
scopic and laparoscopic procedures have further
increased the treatment options available and
challenged the role of routine surgical intervention.
Most authors recommend intervention for pseudo-
cysts greater than 6 cm in size that persist for longer
than 6 weeks.1'5 The rationale for this approach is that
spontaneous resolution may occur within the first 6
weeks, but is unlikely to happen after this time.67 In
addition, the risk of secondary complications, such as
haemorrhage, infection or spontaneous rupture
increases with time.6 The size of the pseudocyst was an
important predictor of the need for operative drainage
in a study by Yeo et al.1 They reported that 67% of
pseudocysts greater than 6 cm in size required surgical
treatment, whereas 40% of those less than 6 cm in size
required operative intervention. It is generally accepted
that small asymptomatic pancreatic pseudocysts can be
managed safely by observation whereas, if the
pseudocyst is symptomatic, enlarging or greater than 6
cm in diameter, intervention should be undertaken,
either after a period of maturation for acute pseudo-
cysts, or immediately for chronic pseudocysts.8
Three patients in this series with acute pseudocysts
were managed with external drainage when the cyst
wall was felt to be immature and not capable of
holding sutures. This technique is the simplest method
of draining a pseudocyst, but is reported to be
associated with a mortality rate of 6% and a recurrence
rate of 22%.9 These figures reflect its predominant
usage in complex cases, such as in patients with recent
severe acute pancreatitis, and those with complicated
pseudocysts, i.e. evidence of infection, haemorrhage or
rupture. Understandably, 10-29% of these patients will
develop an external fistula.'0"'1
The majority of the patients in this series underwent
surgical internal drainage after a minimum of four
weeks from initial presentation. These procedures are
associated with a mortality rate of 2% and a recurrence
rate of 5%.12 Internal drainage can be performed into the
stomach, duodenum or jejunum. Cystduodenostomy is
usually only performed for small cysts in the head of the
pancreas and was undertaken in one patient in this
series. The choice of whether to perform a cystgastro-
stomy or to use a Roux loop of jejunum is usually a
matter of the surgeon's preference, with the results from
these two procedures comparable.13'14 Transgastric cyst-
gastrostomy is a relatively simple approach and is
suitable for drainage of most pseudocysts, as they are
usually adherent to the posterior wall of the stomach.
Cystjejunostomy is felt by some authors to be associated
with a lower complication rate and a lower incidence of
recurrence.8"315-7 However, in a meta-analysis of 1020
patients, the cyst recurrence rate was 2.5% after
cystgastrostomy and 4.5% after cystjejunostomy8 The
majority of patients in this series underwent a cyst-
gastrostomy with minimal morbidity and no evidence of
subsequent recurrence. The risk of recurrence can be
reduced by ensuring that a multiloculated pseudocyst is
completely decompressed and by fashioning a wide
cyst-gastric anastomosis to ensure adequate drainage.
We demonstrated no difference in results after surgery
for patients with pseudocysts arising after acute pan-
creatitis compared with those complicating chronic
pancreatitis, and this is consistent with the findings of
Andersson et al.19
Distal pancreatectomy with resection of a chronic
pseudocyst was performed in four patients in this series.
This procedure is ideally suited for pseudocysts in the
tail of the pancreas particularly when the normal
pancreatic tissue has been replaced by the pseudocyst;8
however, sufficient pancreatic tissue must be left to
ensure adequate endocrine and exocrine function.
Mortality rates of 10% have been reported in association
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with pseudocyst excision.18 On rare occasions a simple
cystectomy may be performed.14
Endoscopic transpapillary stenting is a useful pro-
cedure when a communication between the pancreatic
duct and pseudocyst can be demonstrated.20 A stent is
either passed into the pancreatic duct beyond the level
of the pseudocyst communication or manipulated
directly into the pseudocyst cavity. The former
technique combined with percutaneous drainage of the
pseudocyst was used on one occasion in this series
with good effect. In a review of 117 patients treated by
this method, successful drainage was achieved in 84%
with a recurrence rate of 9% over a mean of two years.2
Other minimally invasive procedures now described
include endoscopic cystgastrostomy or cystduoden-
OSoy2,20-25ostomy,2-5 percutaneous external catheter drainage
under ultrasound or CT guidance,2*29 percutaneous
placement of an internal catheter drain3'31 and, most
recently, laparoscopic procedures for pseudocyst
drainage.3233 Unfortunately, these non-operative tech-
niques are not without their complications, especially
haemorrhage2l1m and sepsis,14'35 which may result in
death. One drawback of these minimally invasive
techniques is that they are not suitable for cases where
the cyst wall is more than 10 mm thick.20 Furthermore,
in a significant number of acute cases, the cyst contents
have solid and liquid elements. In these circumstances,
radiological catheters are prone to clog with pancreatic
debris, which may result in failure of drainage and
secondary infection.14 In addition, peripancreatic
necrosis may be the cause of a persistent pseudocyst.
There is no indication for radiological or endoscopic
techniques in this situation as the pseudocyst will
inevitably recur unless pancreatic necrosectomy is
undertaken at the same time as cystgastrostomy. There-
fore, we believe that surgical intervention is still very
much indicated for a large number of cases and can be
very effective in the management of acute and chronic
pancreatic pseudocysts.
We have demonstrated that surgical internal drainage
can be performed with low morbidity and zero mortality.
However, percutaneous drainage, therapeutic endoscopy
and laparoscopic techniques now offer a variety of
treatment options for symptomatic pancreatic pseudo-
cysts that can be tailored to the needs of individual
patients and guided by the expertise available in each
centre. We feel that surgical internal drainage represents a
very satisfactory treatment option against which less
invasive techniques should be judged. However, we
recognise that these newer techniques have a definite role
and, therefore, recommend a multidisciplinary approach
for the management of this challenging complication of
acute and chronic pancreatitis in a specialist centre.
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